Sildenafil Citrate Tablet, Film Coated
Product Images NDC 68071-3646

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 68071-3646). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3646 1)

Pdp (68071 3646 1)
This is a medication label with information about Sildenafil 50mg tablets from Care Pharmaceuticals, Inc. It includes details like lot number, NDC codes, manufacturer information, expiration date, and instructions to contact a doctor for medical advice about side effects. The label also provides the FDA reporting hotline number and storage instructions.*
FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

Sildenafil_fig1.jpg (Sildenafil Fig1)
The text provides a figure showing the mean change from baseline in sitting systolic blood pressure for healthy volunteers over a period of 20 hours post-dose. The study compares the effects of Sildenafil 100mg with a placebo on systolic blood pressure measurements.*
FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

Sidenafil_fig_5 (Sildenafil Fig 5)
This text mentions a Figure 5 depicting the mean Sildenafil plasma concentrations in healthy male volunteers. The figure likely shows a graph or data related to the levels of Sildenafil in the blood of healthy men.*
FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

Sildenafil-fig7 (Sildenafil Fig7)
Percentage patients reporting improvement: - Placebo: 4% - Sidenail Tablets: 63% - Sideral Tablets: 24% - Sitdari Tablets: 2% This data shows the percentage of patients reporting improvement with different tablets, including Placebo, Sidenail, Sideral, and Sitdari.*
FDA Label Image

Str (Sildenafil Structure)

FDA Label Image

Figure2 (Sildenafil Fig2)

FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.